Perceptive Advisors - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2023$5,404,400
+3963.5%
590,000
+6696.5%
0.16%
+7900.0%
Q2 2020$133,000
+75.0%
8,6810.0%0.00%0.0%
Q1 2020$76,000
+15.2%
8,6810.0%0.00%
+100.0%
Q4 2019$66,000
-99.3%
8,681
-99.3%
0.00%
-99.6%
Q1 2018$9,447,000
-51.8%
1,295,841
-45.8%
0.26%
-59.2%
Q4 2017$19,613,000
-39.7%
2,391,841
-22.8%
0.65%
+4.7%
Q3 2017$32,530,000
+106.4%
3,098,010
+116.8%
0.62%
-21.7%
Q2 2017$15,763,000
+15.6%
1,429,114
+1.5%
0.79%
+2.1%
Q1 2017$13,632,000
-5.5%
1,408,240
+1.4%
0.78%
-24.3%
Q4 2016$14,424,0001,388,2401.03%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2020
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 520,830$2,625,0001.69%
COWEN AND COMPANY, LLC 1,905,990$9,606,0001.57%
Ghost Tree Capital, LLC 825,000$4,158,0001.20%
GENDELL JEFFREY L 1,115,211$5,621,0001.18%
Vivo Capital, LLC 3,526,093$17,772,0001.03%
ACUTA CAPITAL PARTNERS, LLC 705,218$3,554,0000.96%
RTW INVESTMENTS, LP 5,366,705$27,048,0000.65%
BRANDES INVESTMENT PARTNERS, LP 2,840,669$14,317,0000.50%
Avoro Capital Advisors LLC 4,200,000$21,168,0000.30%
HighVista Strategies LLC 57,495$290,0000.21%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders